173 related articles for article (PubMed ID: 20525888)
1. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining.
Falco M; Romeo E; Marcenaro S; Martini S; Vitale M; Bottino C; Mingari MC; Moretta L; Moretta A; Pende D
J Immunol; 2010 Jul; 185(1):433-41. PubMed ID: 20525888
[TBL] [Abstract][Full Text] [Related]
2. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition.
Winter CC; Gumperz JE; Parham P; Long EO; Wagtmann N
J Immunol; 1998 Jul; 161(2):571-7. PubMed ID: 9670929
[TBL] [Abstract][Full Text] [Related]
3. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
[TBL] [Abstract][Full Text] [Related]
4. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
[TBL] [Abstract][Full Text] [Related]
5. Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2.
Vitale M; Carlomagno S; Falco M; Pende D; Romeo E; Rivera P; Della Chiesa M; Mavilio D; Moretta A
Int Immunol; 2004 Oct; 16(10):1459-66. PubMed ID: 15314042
[TBL] [Abstract][Full Text] [Related]
6. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
[TBL] [Abstract][Full Text] [Related]
7. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.
Bottino C; Sivori S; Vitale M; Cantoni C; Falco M; Pende D; Morelli L; Augugliaro R; Semenzato G; Biassoni R; Moretta L; Moretta A
Eur J Immunol; 1996 Aug; 26(8):1816-24. PubMed ID: 8765026
[TBL] [Abstract][Full Text] [Related]
8. KIR2DL2/2DL3-E(35) alleles are functionally stronger than -Q(35) alleles.
Bari R; Thapa R; Bao J; Li Y; Zheng J; Leung W
Sci Rep; 2016 Mar; 6():23689. PubMed ID: 27030405
[TBL] [Abstract][Full Text] [Related]
9. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
Guo KY; Mei JZ; Yao KT
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
[TBL] [Abstract][Full Text] [Related]
10. HLA-C and KIR genes in hepatitis C virus infection.
Montes-Cano MA; Caro-Oleas JL; Romero-Gómez M; Diago M; Andrade R; Carmona I; Aguilar Reina J; Núñez-Roldán A; González-Escribano MF
Hum Immunol; 2005 Nov; 66(11):1106-9. PubMed ID: 16571411
[TBL] [Abstract][Full Text] [Related]
11. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
[TBL] [Abstract][Full Text] [Related]
12. Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand.
Frazier WR; Steiner N; Hou L; Dakshanamurthy S; Hurley CK
J Immunol; 2013 Jun; 190(12):6198-208. PubMed ID: 23686481
[TBL] [Abstract][Full Text] [Related]
13. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
14. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
[TBL] [Abstract][Full Text] [Related]
15. Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Maat W; van der Slik AR; Verhoeven DH; Alizadeh BZ; Ly LV; Verduijn W; Luyten GP; Mulder A; van Hall T; Koning F; Jager MJ; van Bergen J
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2888-95. PubMed ID: 19234348
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors.
Kim J; Chwae YJ; Kim MY; Choi IH; Park JH; Kim SJ
J Immunol; 1997 Oct; 159(8):3875-82. PubMed ID: 9378975
[TBL] [Abstract][Full Text] [Related]
17. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
Kurago ZB; Lutz CT; Smith KD; Colonna M
J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
[TBL] [Abstract][Full Text] [Related]
18. Characterization of KIR
Meazza R; Falco M; Canevali P; Loiacono F; Colomar-Carando N; Muntasell A; Rea A; Mingari MC; Locatelli F; Moretta L; Lopez-Botet M; Pende D
HLA; 2022 Aug; 100(2):119-132. PubMed ID: 35439359
[TBL] [Abstract][Full Text] [Related]
19. Expression of NK cell receptors on decidual T cells in human pregnancy.
Tilburgs T; van der Mast BJ; Nagtzaam NM; Roelen DL; Scherjon SA; Claas FH
J Reprod Immunol; 2009 Jun; 80(1-2):22-32. PubMed ID: 19394706
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes.
Winter CC; Long EO
J Immunol; 1997 May; 158(9):4026-8. PubMed ID: 9126959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
